A Pathological Complete Response After Pembrolizumab for DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer Enabling Curative Surgery: A Case Report
Bernard L Hanekom, Andrew Coveney · 2025
Read A Pathological Complete Response After Pembrolizumab for DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer Enabling Curative Surgery: A Case Report by Bernard L Hanekom, Andrew Coveney (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12741863.txt.
Description
Bernard Hanekom and Andrew Coveney report a case where immunotherapy erased a spreading colon cancer so completely that surgery became curative, in a 2025 case report. Their patient was a forty-nine-year-old man whose mismatch repair-deficient cancer had spread to lymph nodes and liver and could not be removed. Such tumors are unusually sensitive to immune checkpoint drugs, so he received pembrolizumab.
Scans showed the tumors shrinking, but bowel obstructions and a pelvic abscess interrupted treatment, and a team decision sent him to salvage surgery. Pathologists then found no living cancer cells at all in the removed colon, nodes, or liver tissue, a complete pathological response. He resumed the drug after surgery and stayed disease-free at ten months. The authors argue the case proves deep remission, even cure, is possible in this cancer subtype, and they stress routine mismatch repair testing to find the patients who qualify.
Catalog record
| CREATOR | Bernard L Hanekom, Andrew Coveney |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |